1. In Vivo
  2. >>Innovation

Philips At HIMSS22: Informatics Is Taking Pressure Off Providers

The Reinvention Of Health Care Delivery Is Coming Closer

 
• By Ashley Yeo

Workplace pressures are hitting hospitals and providers still feeling the residual effects of the COVID-19 pandemic. Informatics and connected technologies can take much of the strain, said Royal Philips’ connected care chief Roy Jakobs.

Alamy
(Alamy Stock Photo)

HIMSS, the annual Healthcare Information and Management Systems Society meeting, was back “in person” in March 2022, after two years of virtual presentations. Much of the meeting, in Orlando, FL, was additionally run on a virtual track for those unexpectedly caught out by the Omicron variant or simply not wanting to risk the airport crush too early in this post-pandemic phase.

Talking to physical conference attendees via Zoom calls through the digital program, there was a palpable sense of relief that...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Innovation

More from In Vivo

Rising Leaders 2025: Doxie Jordan, From UNC Graduate To Global Market Strategist

 
• By Jo Shorthouse

Bristol Myers Squibb executive Doxie Jordan discusses his path to global commercial leadership and the principles guiding pharmaceutical market strategy

Podcast: Brain+ CEO Discusses “Groundbreaking” Potential Of CST Assistant For Dementia Patients

 
• By Anabel Costa-Ferreira

Devika Wood, CEO of Brain+, explains the importance of developing health tech solutions for dementia and the growing need to both raise awareness and improve overall access to nondrug interventions like CST.

Behind The Buyout: Dispatches From The Dealmaking Table

 
• By Jo Shorthouse

In a challenging funding environment for biopharma, strategic dealmaking has become a critical growth engine. In Vivo explores what it truly takes to navigate high-stakes acquisitions and partnerships, drawing on insights from seasoned industry leaders.